Codexis, Inc. logo

Codexis, Inc.

NASDAQ:CDXS

Overview | Financials
Company Name Codexis, Inc.
Symbol CDXS
Currency USD
Price 3.3
Market Cap 232,840,080
Dividend Yield 0%
52-week-range 1.45 - 4.91
Industry Biotechnology
Sector Healthcare
CEO Dr. Stephen George Dilly MBBS, Ph.D.
Website https://www.codexis.com

An error occurred while fetching data.

About Codexis, Inc.

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In

Related Stocks

Nektar Therapeutics logo

Nektar Therapeutics

NKTR

1.29 USD

Evolus, Inc. logo

Evolus, Inc.

EOLS

11.53 USD

Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc.

RCKT

22.73 USD

The Oncology Institute, Inc. logo

The Oncology Institute, Inc.

TOI

0.532 USD

Merus N.V. logo

Merus N.V.

MRUS

56.66 USD

Verve Therapeutics, Inc. logo

Verve Therapeutics, Inc.

VERV

5.59 USD

SIGA Technologies, Inc. logo

SIGA Technologies, Inc.

SIGA

7.88 USD

Financials

Numbers are in millions USD

Numbers are in millions USD